Verve Therapeutics Inc (VERV)

Dec 19, 2024

SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Verve Therapeutics, Inc.VERV - The Eastern Progress Online

Dec 19, 2024

Dec 19, 2024

Verve Therapeutics Inc Sued for Securities Law ViolationsContact the DJS Law Group to Discuss Your RightsVERV - The Eastern Progress Online

Dec 19, 2024

Dec 18, 2024

VERV Investors Have Opportunity to Lead Verve Therapeutics, Inc. Securities Fraud Lawsuit - The Eastern Progress Online

Dec 18, 2024

Dec 18, 2024

2024-12-18 | Bronstein, Gewirtz & Grossman, LLC Encourages Verve Therapeutics, Inc. (VERV) Investors to Inquire about Securities Investigation | NDAQ:VERV | Press Release - Stockhouse Publishing

Dec 18, 2024

Dec 18, 2024

Bronstein, Gewirtz & Grossman, LLC Encourages Verve Therapeutics, Inc. (VERV) Investors to Inquire about Securities Investigation - AccessWire

Dec 18, 2024

Dec 17, 2024

Verve Therapeutics Slides As Insider Purchases Lose Another US$65k - Yahoo Finance

Dec 17, 2024

Dec 16, 2024

Verve Therapeutics, Inc. Class Action: The Gross Law Firm Reminds Verve Therapeutics Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of October 28, 2024VERV - The Eastern Progress Online

Dec 16, 2024

Dec 16, 2024

Charles Schwab Investment Management Inc. Increases Stake in Verve Therapeutics, Inc. (NASDAQ:VERV) - MarketBeat

Dec 16, 2024

Dec 15, 2024

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Verve Therapeutics, Inc. (VERV) And Encourages Investors to Reach Out - AccessWire

Dec 15, 2024

Dec 15, 2024

2024-12-15 | Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Verve Therapeutics, Inc. (VERV) And Encourages Investors to Reach Out | NDAQ:VERV | Press Release - Stockhouse Publishing

Dec 15, 2024

Dec 14, 2024

Class Action Filed Against Verve Therapeutics, Inc. (VERV) Seeking Recovery for InvestorsContact The Gross Law Firm - Victoria Advocate

Dec 14, 2024

Dec 14, 2024

Verve Therapeutics' SWOT analysis: gene editing firm's stock faces hurdles - Investing.com India

Dec 14, 2024

Dec 14, 2024

Verve Therapeutics' SWOT analysis: gene editing firm's stock faces hurdles By Investing.com - Investing.com Australia

Dec 14, 2024

Dec 14, 2024

VERV Investors Have Opportunity to Lead Verve Therapeutics, Inc. Securities Fraud Lawsuit Filed by The Rosen Law Firm - The Eastern Progress Online

Dec 14, 2024

Dec 14, 2024

Verve Therapeutics, Inc. Sued for Securities Law ViolationsContact The Gross Law Firm Before October 28, 2024 to Discuss Your RightsVERV - The Eastern Progress Online

Dec 14, 2024

Dec 14, 2024

103,348 Shares in Verve Therapeutics, Inc. (NASDAQ:VERV) Purchased by XTX Topco Ltd - MarketBeat

Dec 14, 2024

Dec 12, 2024

Pixalate Releases Q3 2024 EMEA Supply-Side Platform (SSP) Market Share Rankings for Connected TV (CTV), Mobile Apps, & Web: Magnite Leads CTV in Germany (65%) on Amazon Fire TV, Verve No. 1 on Mobile (57%) in Google Play Store - GlobeNewswire Inc.

Dec 12, 2024

Dec 11, 2024

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Verve Therapeutics - The Eastern Progress Online

Dec 11, 2024

Dec 11, 2024

Shareholders that lost money on Verve Therapeutics, Inc.(VERV) Urged to Join Class ActionContact Levi & Korsinsky to Learn More - The Eastern Progress Online

Dec 11, 2024

Dec 11, 2024

Faruqi & Faruqi Reminds Verve Therapeutics Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of October 28, 2024VERV - The Eastern Progress Online

Dec 11, 2024

Dec 11, 2024

VERV Investors Have Opportunity to Lead Verve Therapeutics, Inc. Securities Fraud Lawsuit Filed by the Schall Law Firm - The Eastern Progress Online

Dec 11, 2024

Dec 10, 2024

(VERV) On The My Stocks Page - Stock Traders Daily

Dec 10, 2024

Dec 08, 2024

Companies Like Verve Therapeutics (NASDAQ:VERV) Are In A Position To Invest In Growth - Simply Wall St

Dec 08, 2024

Dec 06, 2024

VERV SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Verve Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - The Eastern Progress Online

Dec 06, 2024

Dec 06, 2024

Jacobs Levy Equity Management Inc. Increases Holdings in Verve Therapeutics, Inc. (NASDAQ:VERV) - MarketBeat

Dec 06, 2024

Dec 05, 2024

Redmile Group LLC Sells 80,040 Shares of Verve Therapeutics, Inc. (NASDAQ:VERV) - MarketBeat

Dec 05, 2024

Dec 03, 2024

Verve Therapeutics: Cutting-Edge Science But Highly Risky Stock - Seeking Alpha

Dec 03, 2024

Dec 03, 2024

PDT Partners LLC Decreases Position in Verve Therapeutics, Inc. (NASDAQ:VERV) - MarketBeat

Dec 03, 2024

Dec 01, 2024

VERV Investors Have Opportunity to Lead Verve Therapeutics, Inc. - GuruFocus.com

Dec 01, 2024